Alexandre Khuskivadze

Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)

Sandip M. Prasad, William C. Huang, Neal D. Shore et al. · The Journal of Urology · 2023 · 44 citations · Full text

Medicine, Surgery, Urology +10

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)

Sandip M. Prasad, Dimitar Shishkov, Nikola V. Mihaylov et al. · The Journal of Urology · 2024 · 34 citations · Full text

Medicine, Oncology, Urology +12

Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin.

D Kochiashvili, Alexandre Khuskivadze, G. Kochiashvili et al. · PubMed · 2014 · 17 citations

Medicine, Pharmacotherapy, Urology +17